CRESTOR SHOWN SIGNIFICANT REDUCTION OF CARDIOVASCULAR RISK IN A LARGE CLINICAL TRIAL
.
Saved in:
Main Author: | статья Редакционная |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Online Access: | https://www.rpcardio.online/jour/article/view/1166 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Press Release Antihypertensive therapy in patients over 80 years is associated with significant reduction in death and cardiovascular event risk
by: статья Редакционная
Published: (2008-08-01) -
RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE OR PERIPHERAL ARTERIAL DISEASE
by: статья Редакционная
Published: (2017-11-01) -
EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL”
by: статья Редакционная
Published: (2016-01-01) -
TELMISARTAN IN CARDIOVASCULAR RISK REDUCTION
by: О. D. Ostroumova, et al.
Published: (2018-02-01) -
CLINICAL MEDICINE UPDATES: A REVIEW OF INTERNATIONAL NEWS
by: статья Редакционная
Published: (2015-10-01)